Using Behavioral Management to Control Chronic Refractory Cough
Noninvasive, efficacious treatment options are available to help patient outcomes and improve quality of life.
CDC Says Fully Vaccinated Individuals can Resume Activities Without a Mask
The CDC considers individuals in the United States to be fully vaccinated 2 weeks after receiving a complete series of COVID-19 vaccine doses.
Higher Dosage of Naloxone Nasal Spray Approved by FDA for Treating Opioid Overdose
This product is a higher dosage of naloxone hydrochloride than the 2 mg and 4 mg dosage products previously approved by the FDA.
Moderna’s COVID-19 Vaccine Receives FDA Committee Recommendation for Emergency Use
This new COVID-19 vaccine (mRNA-1273) candidate was deemed highly effective by an FDA advisory committee.
Remdesivir Trial Demonstrates Positive Results for Patients with COVID-19
Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.
Health Care Organizations Issue Statement on Medications for the Coronavirus
According to the statement, these professional organizations are aware that some physicians and others are prophylactically prescribing medications currently identified as potential treatments for COVID-19.
Access to COVID-19 Medical Supplies Expected to Increase Under Defense Production Act
Federal health officials also said there is increasing capacity for testing to detect the virus.
Medicare's Telehealth Services Expanded for COVID-19 Mitigation
CMS Administrator Seema Verma said the â€œdramatic expansionâ€ will benefit the 62 million beneficiaries across the country enrolled in Medicare.
New Treatment for Adults with Partial-Onset Seizures Granted FDA Approval
The FDA has approved cenobamate tablets (XCOPRI, SK Life Sciences) for treatment of partial-onset seizures in adults.
2 Clarke Drive Cranbury, NJ 08512